Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News ImmunoGen Inc IMGN

ImmunoGen, Inc. is a commercial-stage biotechnology company. The Company is focused on developing and commercializing of antibody- drug conjugates (ADCs) to improve outcomes for cancer patients. An ADC with the Company’s technology comprises an antibody that binds to a target found on tumor cells and is conjugated to one of its potent anti-cancer agents as a payload to kill the tumor cell once... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Current News (NDAQ:IMGN)

No current news is available.

Opinion & Analysis (NDAQ:IMGN)

No current opinion is available.

Bullboard Posts (NDAQ:IMGN)

IMGN - Wednesday Rundown, Thursday Expectations

<< View Post To Watch Video >>
HDavis - December 1, 2021

IMGN - Tuesday Rundown, Wednesday Expectations

<< View Post To Watch Video >>
HDavis - November 30, 2021

IMGN - Is Set Up For A Run

<< View Post To Watch Video >>
HDavis - November 30, 2021

this one is holding up well

considering the markets,so glta shareholders.
coolfooldumbguy - February 25, 2020

still holding this stock

my new target price for this year is over $10 plus per share and MORE,so glta shareholders.
coolfooldumbguy - February 14, 2020

past my target price

but won't sell it yet,my target was the $6 per share mark,but because this stock blew past it with all kinds of strength showing on...
coolfooldumbguy - February 14, 2020